OXO CHEMIE Inc.


Mar 07, 00

07:03 ET WF10 Modifies Cytokine Gene Expression

 
Dec 21, 99

13:44 ET Raimund Eckel, Ph.D. Joins OXO Chemie AG as President and Chief Executive Officer

 
Dec 06, 99

17:01 ET OXO Chemie Presents Exciting Data of Quantitatively Detectable Changes of Gene Expression Pattern in Macrophage and PBMCs of Patients Treated With WF10 At the 4th International Workshop on HIV, Cells of Macrophage Lineage, And Other Reservoirs

 
13:32 ET OXO Chemie Presents Exciting Data of Quantitatively Detectable Changes of Gene Expression Pattern in Macrophage and PBMCs of Patients Treated With WF10 At the 4th International Workshop on HIV, Cells of Macrophage Lineage, And Other Reservoirs

 
Apr 08, 99

15:48 ET Canadian Sites Approved for Phase 3 Clinical Trial of WF10, an Innovative Immune Approach for Advanced HIV Disease

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.